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RING (Really Interesting New Gene) domain-containing E3 ubiquitin ligases comprise a
large family of enzymes that in combination with an E2 ubiquitin-conjugating enzyme,
modify target proteins by attaching ubiquitin moieties. A number of RING E3s play an
essential role in the cellular response to DNA damage highlighting a crucial contribution for
ubiquitin-mediated signaling to the genome surveillance pathway. Among the RING E3s,
RNF8 and RNF168 play a critical role in the response to double stranded breaks, one of the
most deleterious types of DNA damage. These proteins act as positive regulators of the
signaling cascade that initiates at DNA lesions. Inactivation of these enzymes is sufﬁcient
to severely impair the ability of cells to respond to DNA damage. Given their central role
in the pathway, several layers of regulation act at this nodal signaling point. Here we will
summarize current knowledge on the roles of RNF8 and RNF168 in maintaining genome
integrity with particular emphasis on recent insights into the multiple layers of regulation
that act on these enzymes to ﬁne-tune the cellular response to DNA lesions.
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INTRODUCTION
Eukaryotic cells have evolved sophisticated mechanisms to detect
and repair different types of DNA lesions, collectively referred
to as the DNA damage response (DDR). In response to DNA
lesions this pathway marks the damaged DNA, activates cell cycle
checkpoints that halt cellular proliferation and activates the DNA
damage repair machinery. Double strand DNA breaks are among
the most deleterious types of DNA lesions and, strikingly, the
presence of only a few DNA damage sites is sufﬁcient to fully
engage the DDR pathway resulting in a robust cell cycle inhi-
bition (Bakkenist and Kastan, 2003). Several steps of regulation
must ensure that the damage signal does not spread beyond the
site of lesion and that its activation is reversed only upon com-
pletion of the DNA repair events. We now appreciate that an
efﬁcient response to DNA damage involves transcriptional reg-
ulation, micro-RNA biogenesis, detection of methylated histone
tails, and multiple posttranslational modiﬁcation events including
phosphorylation, sumoylation, and ubiquitylation.
In this review, we will focus on the role of ubiquitin signaling
in the response to double stranded breaks (DSBs). In recent years,
an expanding view of ubiquitylation as a means to modulate the
timing and efﬁciency of the repair process and to recruit factors
to the sites of DNA lesions has emerged. Ubiquitin (Ub) is an
essential 76-amino-acid protein conserved from yeast to humans.
Ubiquitylation is a three-step enzymatic process through which
ubiquitin becomes covalently attached to speciﬁc target proteins.
First, ubiquitin is activated by an E1 activating enzyme via anATP-
dependent reaction to form an E1-Ub thioester bond. Then, the
activated ubiquitin is transferred to an E2 conjugating enzyme.
Finally, an E3 ligase catalyzes the transfer of ubiquitin to a target
protein through formation of an isopeptide bond between the
carboxyl-terminus of ubiquitin and a lysine (K) residue on the
target protein (Ciechanover et al., 1982; Hershko et al., 1983). It is
the E3 enzyme that confers the majority of the substrate speciﬁcity
to the ubiquitylation cascade through recognition of a distinct set
of target proteins.
The two major classes of E3 ligases are the RING (really inter-
esting new gene)/Ubox domain-containing E3s and the HECT
(homologous to E6-associated protein C-terminus) domain-
containing E3s. While HECT E3s form an intermediate thioester
bond with ubiquitin, RING E3s act as scaffolds, facilitating
ubiquitylation by bringing the E2 and substrate close together.
RING ﬁnger ubiquitin ligases comprise one of the largest fam-
ilies of enzymes in human cells with more than 600 members
(Deshaies and Joazeiro, 2009). They are themost abundant class of
E3s and regulate many crucial cellular functions, such as cell cycle
progression, DDR, DNA repair, cell signaling, and response to
hypoxia (reviewed in Lipkowitz and Weissman, 2011). RING E3s
catalyze target monoubiquitylation or polyubiquitylation assem-
bled via different lysine residues of ubiquitin,which have a range of
different biological effects, from proteasomal degradation (K48-
linked polyubiquitylation) to regulation of DNA repair, receptor
internalization, and gene silencing, among others (monoubiquity-
lation and/or K63-linked polyubiquitylation; Johnson, 2002; Sun
and Chen, 2004).
Highlighting the relevance for ubiquitin signaling in organism
homeostasis, mutations in RING E3s are frequently associated
with human diseases such as BRCA1 (breast cancer type 1 sus-
ceptibility protein) mutations in patients with breast and ovarian
cancer (Hashizume et al., 2001; Ruffner et al., 2001), and MDM2
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(mouse doubleminute 2 homolog) ampliﬁcation in several human
cancers (Oliner et al., 1992; Wade et al., 2010).
Multiple RING E3s play a central role in various DDR pathways
and are involved in either sensing or repairing DNA lesions, some
of which are listed in Table 1.
In this review, we will focus primarily on RNF8 (RING ﬁnger
8) and RNF168 (RING ﬁnger 168), which are essential in the
cellular response to DSBs and appear to form a key nodal point of
regulation to modulate the DSB response and repair pathway.
We will also describe recently reported cross-talks between
the RNF8/RNF168 pathway and other cellular components: (i)
RING E3s of the polycomb group (PcG) complex PRC1 (poly-
comb repressive complex 1), which are emerging as potential novel
players in the response to DSBs, where they appear to primarily
contribute to the transcriptional silencing that occurs at sites of
DNA lesions; (ii) proteins involved in small ubiquitin-like modi-
ﬁer (SUMO) signaling, whose role in DSB repair and response is
becoming increasingly evident.
RNF8/RNF168: MAJOR PLAYERS IN THE DETECTION OF DNA
DOUBLE STRAND BREAKS
The response to DSBs is initiated by the phosphatidylinosi-
tol 3-kinase-related kinase ATM (ataxia-telangiectasia mutated),
which rapidly accumulates at DNA lesions in a MRN
(MRE11/RAD50/NBS1)-dependent manner (Bekker-Jensen et al.,
2006). ATM activation results in the phosphorylation of the
histone variant H2AX on serine 139 (referred to as γ-H2AX).
This marks the nucleosomes surrounding the DNA lesion and
serves as an anchoring platform for the subsequent accumulation
of downstream signaling proteins to DSB sites (Rogakou et al.,
1998; Burma et al., 2001). MDC1 (mediator of DNA damage
checkpoint 1) binds directly to γ-H2AX via its BRCT domains
(Stucki et al., 2005). MDC1 recruitment results in ampliﬁcation
of the DNA damage signal by promoting further accumulation
of the MRN complex at DSBs (Chapman and Jackson, 2008;
Melander et al., 2008; Spycher et al., 2008). RNF8 and RNF168
are recruited at this step in the DDR pathway in an MDC1-
dependent manner (Figure 1). RNF8 localizes to DSBs via its
N-terminal forkhead-associated (FHA) domain, which interacts
with the ATM-phosphorylated TQXF motifs on MDC1 (Huen
et al., 2007; Kolas et al., 2007; Mailand et al., 2007). In concert with
the E2 enzyme UBC13, the ligase activity of the C-terminal RNF8
RING ﬁnger domain is responsible for the recruitment of BRCA1
and 53BP1 (p53 binding protein 1; see below for more details;
Wang and Elledge, 2007).
Historically, evidence has suggested that the targets of RNF8-
UBC13 at DSBs are the histones H2A and H2AX, as they were
shown to be ubiquitylated in response to DSBs in an RNF8-
dependent manner (ubiquitylated H2A, uH2A; Huen et al., 2007;
Mailand et al., 2007). Depletion of RNF8 leads to an impaired
G2/M checkpoint at low doses of ionizing radiation (IR) and
hyper-sensitivity to IR, indicating that the RNF8-dependent sig-
naling is critical for the cellular response to DNA damage (Huen
et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Wang and
Elledge, 2007).
RNF168 was identiﬁed in genome-wide screens as a factor nec-
essary for IR-induced 53BP1 focus formation (Doil et al., 2009;
Stewart et al., 2009). Signiﬁcantly, mutations of RNF168 are
associated with the RIDDLE syndrome (radiosensitivity immun-
odeﬁciency dysmorphic features and learning difﬁculties), which
is characterized by cellular defects in repairing DSBs. Cells derived
from RIDDLE patients fail to recruit 53BP1 and BRCA1 at
irradiation-induced DNA damage sites (IRIFs) and can be com-
plemented by exogenous RNF168 expression (Stewart et al., 2009).
RNF168 is a RING-type ubiquitin ligase that also works with the
UBC13 E2 enzyme. The RING domain of RNF168 is not required
for recruitment at DNA lesions, which is instead dependent on
its two ubiquitin-binding motifs MIU1 and MIU2 (motif inter-
acting with ubiquitin; Doil et al., 2009; Pinato et al., 2009; Stewart
et al., 2009; Panier et al., 2012). However, the catalytic activity of
RNF168 is required for the accumulation of 53BP1 and BRCA1 at
sites of damage. RNF168 activity is also required for the accumu-
lation of IR-induced uH2A, an activity that can be recapitulated in
vitro (Doil et al., 2009; Stewart et al., 2009). RNF168 recruitment
at damage sites is RNF8-dependent, while RNF8 is recruited to
DSBs in a RNF168-independent manner (Doil et al., 2009; Stew-
art et al., 2009). These data supported the widely accepted model
for the sequential recruitment of RNF8 and RNF168 at sites of
DNA damage, whereby RNF8 would initiate ubiquitin conjuga-
tion on histones H2A and H2AX. Subsequently, RNF168 would be
recruited at damaged sites through the binding of itsMIUdomains
to uH2A, resulting in further ampliﬁcation of the ubiquitin signal
Table 1 | RING finger E3s involved in DDR pathways.
RING E3 Target Ubiquitylation type Function
RNF8 H2A/H2AX and other unknown K63 chains DSB signaling and repair
RNF168 H2A/H2AX Mono on K13-15 of H2A/H2AX and K63 chains DSB signaling and repair
BRCA1 Unknown K6 and other unknown? Promote HR
BMI1 H2A (H2AX?) Mono on K119 of H2A Gene silencing; DSB signaling?
RING1B H2A (H2AX?) Mono on K119 of H2A Gene silencing; DSB signaling?
RAD18 PCNA Mono on K164 of PCNA PRR
FANCL FANCD2/FANCI Mono on K561 of FANCD2, on K523 of FANCI ICL repair (FA pathway)
Mono, monoubiquitylation; PRR, post-replication repair; ICL, inter-strand crosslink; FA, Fanconi anemia.
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FIGURE 1 | Model of RNF8/RNF168-mediated ubiquitylation at
DSBs. RNF8 is recruited to DSBs through its interaction with MDC1.
Chromatin-bound RNF8 cooperates with the E2 UBC13 to ubiquitylate an
unknown non-nucleosomal target in the vicinity of the damaged chromatin
(X). Ubiquitylated target-X is recognized by RNF168, which catalyzes
monoubiquitylation of K13-15 on H2A-type histones. RNF8 and RNF168
work in concert to extend the ubiquitin chains on H2A-type histones.
BRCA1 and 53BP1 are recruited as downstream effectors. BRCA1
accumulates at DSBs in an RNF8/RNF168-dependent manner, through
RAP80, which binds to the K63-linked ubiquitin chains deposited by
RNF8/RNF168. The RAP80–BRCA1 complex is thought to inhibit excessive
HR, while BRCA1 in complex with several other DNA damage response
proteins is known to primarily promote DNA repair by HR. 53BP1
accumulation at DSBs depends on RNF8/RNF168-mediated modiﬁcations
to the chromatin surrounding the DNA lesion. 53BP1 promotes DNA repair
by NHEJ (Me, methylation of H4K20).
via the formation of K63-linked polyubiquitin chains (Panier and
Durocher, 2009). This model has been recently challenged by the
discovery that RNF8 is inactive toward nucleosomal H2A (Mat-
tiroli et al., 2012). This study provides evidence that the initial
ubiquitylation of histone H2A is mediated by RNF168 at K13-15.
The authors propose a model in which RNF8 is responsible for
the ubiquitylation of other non-nucleosomal proteins localized
at the DNA damage site, which would represent the docking site
for RNF168. Thus, recruitment of RNF168 in this model is still
dependent on RNF8 but does not involve ubiquitylation of nucle-
osomal H2A (or H2AX) as the priming step. RNF168 catalyses the
monoubiquitylation of H2A and H2AX at K13-15. Subsequently,
K63-linked ubiquitin chains can be conjugated by both E3 ligases
in concert (Figure 1). This model is also in keeping with a recent
report from the Durocher laboratory, which suggests the existence
of two waves of RNF168 recruitment to DSBs: an initial tran-
sient recognition of RNF8-dependent ubiquitylation, followed by
a more stable association to DSB-ﬂanking chromatin promoted by
RNF168 catalytic activity itself (Panier et al., 2012).
DNA damage-induced non-proteolytic polyubiquitin chains
catalyzed by RNF8 and RNF168 in DSB-ﬂanking chromatin serve
as binding sites for the recruitment of the downstream effec-
tors of the DDR pathway BRCA1 and 53BP1 (Figure 1, bottom
panel) (Kolas et al., 2007; Mailand et al., 2007; Wang and Elledge,
2007; Doil et al., 2009). The relative dynamics with which these
two components accumulate at break sites is extremely important
to determine the choice of repair pathway the cell will take to
ensure genome stability, underscoring the central role played by
RNF8/RNF168 in orchestrating the DDR and repair pathways.
In mammalian cells, DSBs are predominantly repaired by the
homologous recombination (HR) and the non-homologous end-
joining (NHEJ) pathways. NHEJ is the primary repair mechanism
during G0-, G1-, and early S-phases of the cell cycle (Delacote and
Lopez, 2008). The NHEJ process ligates the broken DNA molecule
back together and, due to the varying levels of end processing
prior to end-joining, this pathway is often error-prone (reviewed
in Lieber, 2008). Conversely, the HR pathway is an error-free
repair process that utilizes the sister chromatid as a template to
repair damaged DNA and is thus only active in the S/G2 phase of
the cell cycle (Moynahan et al., 1999; Wyman and Kanaar, 2006).
53BP1 and BRCA1 have reciprocal roles in DSB repair: BRCA1
is required for efﬁcient HR, while 53BP1 promotes NHEJ (see
Figure 1; Nakamura et al., 2006; Xie et al., 2007; Diﬁlippantonio
et al., 2008; Dimitrova et al., 2008; Yun and Hiom, 2009). Several
recent reports have shown how the antagonism between these two
proteins is important for DSB repair pathway choice and con-
sequent cell survival. A striking example of this antagonism is
provided by cells that have impaired BRCA1 activity: inhibition of
53BP1 in this background is able to restore viability and suppress
genomic instability associated with defective BRCA1, by allow-
ing resection of DSBs and repair via the HR pathway to occur
(Bouwman et al., 2010; Bunting et al., 2010). Below we will sum-
marize current knowledge on how RNF8 and RNF168-dependent
signaling recruits these important factors to sites of DSBs.
MECHANISMS OF RNF8/RNF168-DEPENDENT RECRUITMENT
OF DOWNSTREAM EFFECTOR PROTEINS
53BP1
Recruitment of 53BP1 to damaged chromatin was shown to occur
via recognition of dimethylated histone H4 on K20 (H4K20me2)
by its tandem Tudor domain (Sanders et al., 2004; Botuyan
et al., 2006). 53BP1 does not contain any known ubiquitin-
binding motifs and therefore the mechanism through which
RNF8/RNF168 mediates its recruitment is still not fully under-
stood. Recent ﬁndings from different groups point to a model
in which RNF8/RNF168-dependent ubiquitylation at DSBs is
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necessary to remove factors that bind to H4K20me2 sites, thus
unmasking the sites for 53BP1 binding. Meerang et al. (2011)
demonstrated that RNF8 is responsible for the recruitment of
the AAA ATPase p97/VCP to the sites of DNA damage via both
K63- and K48-linked ubiquitin chains. p97/VCP was shown to
be in turn responsible for the removal of the polycomb pro-
tein L3MBTL1 from H4K20me2 histones at damage sites (Acs
et al., 2011). These ﬁndings suggest that removal of L3MBTL1 is
necessary for 53BP1 binding to H4K20me2, although this hypoth-
esis remains to be fully validated. In another study by Mallette
et al. (2012), RNF8/RNF168-dependent unmasking of H4K20me2
sites was indeed found to be involved in 53BP1 recruitment to
DSBs. In their work, the authors show that the Tudor domain-
containing lysine demethylases JMJD2A and JMJD2B, which
bind to H4K20me2, become polyubiquitylated and degraded in
response to DNA damage and that this requires the E3 ligase
activity of both RNF8 and RNF168. The combined knockdown
of JMJD2A and JMJD2B signiﬁcantly rescued the ability of RNF8-
andRNF168-deﬁcient cells to form 53BP1 foci uponDNAdamage
induction, indicating that the RNF8/RNF168-dependent degra-
dation of the lysine demethylases controls the recruitment of
53BP1 at DNA damage sites. Although these ﬁndings indicate that
removal of H4K20me2-binding proteins is certainly important for
the recruitment of 53BP1 to DSBs, it is likely that other mecha-
nisms exist which could explain the requirement for H2AK13-K15
ubiquitylation in this process (Mattiroli et al., 2012). An additional
mechanism that may contribute to 53BP1 DSB recruitment is the
DNA damage-induced chromatin relaxation that occurs at sites of
DNA lesions, which may allow H4K20me2 to be more accessible
for 53BP1 binding (Xu et al., 2010; Luijsterburg and van Attikum,
2012). A more detailed description of this process will be provided
in Section “Chromatin Remodeling” of this review.
BRCA1
BRCA1 is a RING E3 ubiquitin ligase and is recruited to DNA as
a dimer with BARD1 (BRCA1-associated RING domain 1), which
enhances BRCA1 RING domain ligase activity in vitro. BRCA1
has multiple roles in the DDR and repair pathways, underscored
by its recruitment to damaged DNA in several different complexes.
These complexes have functions in sensing DNA damage, control-
ling cell cycle checkpoints, and recruiting DNA repair enzymes to
orchestrate the cross-talk of the DNA repair pathways with vari-
ous cellular processes (Huen et al., 2010). It is generally accepted
that the main function of BRCA1 in DNA repair is to promote
HR (reviewed in Yun and Hiom, 2009; Caestecker and Van de
Walle, 2013). At DSBs, BRCA1 is recruited to RNF8/RNF168-
generated ubiquitin chains as part of the BRCA1-A complex
[containing BRCA1, BARD1, RAP80 (receptor-associated pro-
tein 80), ABRAXAS, BRCC36, BRE, and NBA1] through RAP80,
which binds to the K63-linked ubiquitin chains deposited by
RNF8/RNF168 at DNA lesions via its two N-terminal UIMs (ubiq-
uitin interacting motif; Kim et al., 2007; Sobhian et al., 2007;
Wang and Elledge, 2007; Wang et al., 2007). The exact role of
the BRCA1-A complex is not fully understood; although RAP80-
and ABRAXAS-depleted cells display mild defects in HR (Wang
et al., 2007), recent reports have shown that the BRCA1–RAP80
complex can inhibit HR by restricting end-resection (Coleman
and Greenberg, 2011; Hu et al., 2011). Further work is required to
establish the exact role of the different BRCA1 complexes in the
repair of DSBs.
MODULATION OF THE RNF8/168 PATHWAY
The choice of the DNA repair mechanism is crucial for cell sur-
vival after genotoxic insult. The relative accumulation at DSBs of
53BP1 and BRCA1, which determines this choice, is dependent
on RNF8/RNF168, underscoring the necessity of a highly strin-
gent regulation mechanism for these enzymes. In the following
sections, we will illustrate the various means by which mammalian
cells are able to achieve multiple layers of regulation in order to
tightly control RNF8/RNF168 signaling, with particular focus on
recent reports in the ﬁeld. We will also describe how regulation of
RNF8/RNF168 is exploited in different settings: by the telomere
protection machinery to safeguard the integrity of chromosome
ends, and by viruses during infection of mammalian cells.
CHROMATIN REMODELING
Chromatin remodeling plays an important role in the DDR path-
way to create a local chromatin environment that facilitates the
assembly of checkpoint response and repair factors (reviewed in
Luijsterburg and van Attikum, 2012; Soria et al., 2012). Indeed,
several chromatin remodeling factors are recruited to sites of DNA
damage and have been shown to modulate the activity of RNF8
and RNF168 at sites of damage.
p400, the catalytic subunit of the NuA4 histone acetyltrans-
ferase complex, is recruited at DSBs in a MDC1-dependent
manner (Xu et al., 2010). Interestingly, in the absence of p400,
while RNF8 is still recruited to DSBs, polyubiquitin chains are
not formed at the sites of damage. As a consequence, BRCA1
and 53BP1 recruitment is impaired and p400-deﬁcient cells show
radiosensitivity and chromosomal aberrations. The mechanism
through which this occurs is still unclear, but the authors specu-
late that chromatin relaxation may alter the nucleosome structure
to expose previously buried histone domains, which can then be
targeted by RNF8. In the light of the recent report from the Sixma
groupdescribed above, one possibility is that p400-mediated chro-
matin relaxation is an important step to expose lysine residues on
a so far unidentiﬁed RNF8 target (see model in Figure 2). This
nucleosome destabilization was also suggested to contribute to
exposure of methylated histone residues for binding of 53BP1.
A similar function seems to be played by CHD4 (chromod-
omain helicase DNA binding protein 4) of the NuRD histone
deacetylase complex. CHD4 is recruited to laser-induced DNA
damage sites in aRNF8-dependentmanner,where it promotes efﬁ-
cient RNF8-mediated ubiquitin conjugation and recruitment of
downstream factors RNF168 and BRCA1, presumably by favoring
chromatin decondensation (Luijsterburg et al., 2012). Interest-
ingly, RNF8 interaction with CHD4 involves the FHA domain
of RNF8 while it does not require E3 catalytic activity.
Finally, SMARCA5, an ATPase contained in several distinct
ISWI chromatin remodeling complexes has been shown to have a
role in RNF8/RNF168-dependent DDR signaling (Smeenk et al.,
2012). Smeenk and colleagues show that SMARCA5 is recruited
to DSBs induced by laser micro-irradiation and its depletion
increases IR-sensitivity and impairs both the HR and NHEJ repair
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FIGURE 2 | Chromatin decondensation at DSBs.The chromatin
remodeling factors p400 and CHD4 mediate large-scale chromatin
decondensation at DSB sites, promoting RNF8/RNF168-mediated
ubiquitylation and other chromatin modiﬁcations. P400 is recruited by
MDC1, CHD4 by RNF8. SMARCA5 is recruited through RNF168 and
promotes its activity at DSBs.
pathways. SMARCA5 and RNF168 interact at DSBs in a mutually
dependent fashion that requires the catalytic activity of PARP1.
Surprisingly, SMARCA5-depleted cells do not display any defect
in 53BP1 accumulation at IRIFs, even though ubiquitin conjuga-
tion and BRCA1 assembly were signiﬁcantly reduced. This implies
that either the threshold for ubiquitin levels required to promote
BRCA1 or 53BP1 recruitment differs, or that alternative mecha-
nisms of 53BP1 recruitment exist when the SMARCA5-RNF168
response is impaired. Further studies will be required to establish
how SMARCA5 and the other chromatin remodeling enzymes
described above remodel chromatin in the vicinity of DSBs to
promote the RNF8/RNF168 signaling cascade, thereby promoting
genomic stability in response to genotoxic insult.
Collectively, these data suggest a “chromatin remodeling-
assisted ubiquitylation” activity for RNF8 and RNF168. In this
model p400 and CHD4 are required to promote the initial ubiqui-
tylation events at DNA damage sites that are needed to recruit
RNF168, which, in turn, propagates the ubiquitylation signal
and promotes accumulation of downstream effectors. In addition,
SMARC5 plays a role at the level of RNF168 promoting its activity
following the initial ubiquitylation event (see model in Figure 2).
DE-UBIQUITYLATION ACTIVITIES AT SITES OF DNA DAMAGE
Ubiquitin-mediated signaling at sites of DNA damage can be
attenuated or turned off by the action of de-ubiquitylating
enzymes (DUBs; Sowa et al., 2009).
The human genome encodes nearly 100 DUBs that are divided
into ﬁve classes based on their mechanism of catalysis (Nijman
et al., 2005). The ﬁrst four classes are papain-like cysteine proteases
and include: the ubiquitin C-terminal hydrolases (UCHs), the
ubiquitin-speciﬁc proteases (USPs), the ovarian tumor proteases
(OTUs), and the Josephines. The ﬁfth class is composed of the
JAB1/MPN/MOV34 metalloenzymes (JAMMs), which are zinc-
dependent metalloproteases.
To date, four DUBs have been shown to counteract the action
of RNF8/RNF168 on H2A/H2AX (see Figure 3): USP3, USP16
(ubiquitin-speciﬁc protease 3 and 16, respectively), BRCC36
(BRCA1/BRCA2-containing complex subunit 36) and OTUB1
(OUT domain ubiquitin aldehyde-binding 1).
USP3 has been shown to be a negative regulator of the
RNF8/RNF168 pathway through its de-ubiquitylating activity
(Nicassio et al., 2007). Overexpression of USP3, while having
no effect on retention of RNF8 at DSBs, abolished the IR-
induced focus formation of RNF168, RAP80, and 53BP1 (Doil
et al., 2009), indicating that it de-ubiquitylates RNF8-targeted
substrates.
USP16 is the major DUB for uH2A and acts as an antago-
nist of polycomb-dependent repression of gene expression (Joo
et al., 2007). An ATM-dependent transcriptional silencing at DSBs
has been reported, and seems to be at least partially mediated
FIGURE 3 | Modulation of RNF8/RNF168 signaling through
de-ubiquitylation. Different DUBs act at different levels of the
RNF8/RNF168 cascade to inhibit, modulate, or turn off the ubiquitin signal
generated by the two E3s. USP3 de-ubiquitylates RNF8 targets; OTUB1
acts on substrates of RNF168, and BRCC36 acts downstream, severing
ubiquitin chains generated presumably by both E3s (and possibly also on
BRCA1 targets, indicated by the dashed arrow).
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by the ubiquitin mark deposited by RNF8/RNF168 at H2A. This
transcriptional repression at DSBs can be alleviated by inhibition
of ATM (ATMi). USP16 depletion could prevent ATMi-mediated
restoration of transcription, indicating that this DUB is respon-
sible for de-ubiquitylation of uH2A at DSBs (Shanbhag et al.,
2010). Whether the target for USP16-mediated de-ubiquitylation
is uH2AdepositedbyRNF8/RNF168or byother E3 ligases remains
to be established (see “RING E3 Polycomb Proteins and the
RNF8/RNF168 DSB Response Pathway” Section for more details).
The K63-speciﬁc BRCC36 is recruited to DSBs as part of
the BRCA1-A complex (Shao et al., 2009). BRCC36-depletion
increases DSB-associated ubiquitin and 53BP1 accumulation at
DSBs. This increase is partially reversed following RNF8 deple-
tion, consistent with a role for BRCC36 as negative regulator of
the RNF8/RNF168 pathway via de-ubiquitylation of K63-linked
ubiquitin chains. Although the reasons for the presence of a de-
ubiquitylase function in the context of a complex that recognizes
ubiquitin chains are not fully understood, it has recently been pro-
posed that BRCC36 may function to remove K63-linked ubiquitin
from one substrate, allowing BRCA1 to mediate the formation of
K6-linked chains on the same or other substrates, thus providing
a dynamic balance between formation and removal of ubiquitin
signals at DSBs, potentially important for the subsequent steps of
repair (Wu et al., 2012).
Finally, theDUBOTUB1was also shown tobe anegative regula-
tor of the RNF8/RNF168 pathway, at the level of RNF168 (Nakada
et al., 2010), albeit in a non-canonical fashion. Indeed, the ability
of OTUB1 to inhibit RNF168-dependent ubiquitylation is inde-
pendent of its catalytic activity, and is instead mediated by its
binding to and inhibition of the E2 UBC13, which cooperates
with RNF168, suggesting that E2 regulation could also represent a
means to regulate the DDR pathway.
The concerted action of the DUBs described above has
an important contribution in counteracting RNF8/RNF168-
mediated ubiquitin signaling to prevent excessive spreading of
damage signals at DSBs and to terminate the signal after repair
processes have occurred (Figure 3). It is likely that additional
DUBs acting on other RNF8/RNF168 targets and/or with different
ubiquitin-conjugate speciﬁcity remain to be identiﬁed.
REGULATION OF PROTEIN STABILITY
An additional level of regulation that was recently uncovered acts
at the level of RNF168 protein stability (Gudjonsson et al., 2012).
Gudjonsson and colleagues show that RNF168 is a target for the
HECT domain-containing E3s ligases, TRIP12 and UBR5, which
reduce the pool of available nuclear RNF168 by targeting it for
proteasomal-mediated degradation. Given the processive nature
of RNF168 and its persistent self-recruitment to damaged DNA,
this regulation is critical to limit the cellular levels of RNF168
and thus prevent excessive spreading of DNA damage-induced
chromatin ubiquitylation and consequent hyper-accumulation of
ubiquitin-mediated genome caretakers to undamaged regions of
the genome (Figure 4). Indeed, in TRIP12/UBR5-depleted cells
IR-induced 53BP1 foci are larger indicating hyper-accumulation
and excessive spreading of these DDR factors along the chro-
matin. This has important consequences on DSB repair efﬁciency
and consequent cell survival. Boosting chromatin ubiquitylation
FIGURE 4 |TRIP12 and UBR5-mediated suppression of DSB-induced
chromatin ubiquitylation.The HECT E3 ligasesTRIP12 and UBR5 control
the nuclear pool of RNF168 (top). If TRIP12 and UBR5 are depleted,
hyper-accumulation of RNF168 triggers excessive spreading of ubiquitylated
H2A/H2AX far away from the initial site of DNA lesion (bottom).
by inhibiting TRIP12/UBR5 enhances the repair efﬁciency of
IR-induced DSBs by increasing rates of NHEJ, consistent with
increased loading of 53BP1 on damaged chromatin. Interestingly,
a more modest but nonetheless signiﬁcant increase in HR rates
could also be observed in the same experimental settings. The
authors speculate that this could be due to hyper-accumulation
of BRCA1 at sites of DNA lesions, which also is observed in
TRIP12/UBR5-depleted cells and which could facilitate HR of
unresolved DSBs close to the G2/M transition, when progressive
chromatin condensation starts to displace NHEJ factors such as
53BP1. In addition to a faster and/or more efﬁcient repair of
DSBs, TRIP12/UBR5-depleted cells also displayed an improved
short-term survival rate after irradiation, indicating that RNF168
overproducing cells could provide selective advantage to cancer
cells that proliferate under increased genotoxic stress. Aberra-
tions of both TRIP12 and UBR5 have been described in certain
types of cancer (Clancy et al., 2003; O’Brien et al., 2008; Yoo et al.,
2011), and elevated RNF168 protein levels and expanded 53BP1
foci were found in a subset of advanced human papillomavirus
(HPV)-positive tumors (Gudjonsson et al., 2012), suggesting that
the homeostasis of ubiquitin signaling achieved through regula-
tion of RNF168 levels as illustrated here could be subverted during
tumorigenesis.
AnotherHECTE3 ligase,HERC2, hadbeenpreviously reported
by the same group to have an opposite effect on RNF168 protein
levels, by promotingRNF168 stability and therefore facilitating the
assembly of repair factors to DSBs (Bekker-Jensen et al., 2010). In
addition, the authors also showed thatHERC2was able to promote
DSB signaling and repair by facilitating the assembly of RNF8
with its E2 partner UBC13, thus underscoring the importance of
yet another E3 ligase, HERC2, in the RNF8/RNF168-dependent
pathway in response to DSBs.
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DOWNSTREAM REGULATION BY RNF169 COMPETITIVE BINDING TO
RNF8/RNF168 UBIQUITYLATED TARGETS
The RNF168 paralog RNF169 was recently identiﬁed as a novel
RING E3 ligase with an unexpected negative role in the DNA
damage-induced ubiquitin signaling response. RNF169 has a sim-
ilar domain architecture to RNF168, including an N-terminal
RING ﬁnger domain and UMI and MIU motifs and a C-terminal
MIU motif (Panier et al., 2012; Poulsen et al., 2012). However, the
nature of RNF169 recruitment to sites of damage is different to
that observed for RNF168. Indeed, while RNF168 recruitment
involves interaction with RNF8 targets through its N-terminal
UBD region, the corresponding domain in RNF169 is dispens-
able for RNF169 localization. Instead, RNF169 accumulates at
IRIFs in an RNF168-dependent manner by binding to RNF168-
dependent ubiquitin products through its C-terminal MIU2.
Functional studies demonstrated that while RNF169 is dispens-
able for ubiquitin-dependent protein assembly at DSB foci, its
overexpression leads to impaired recruitment of 53BP1, BRCA1,
RAP80, and RAD18 at these sites. Therefore, it was proposed
that RNF169 competes with these DDR factors for binding to
RNF168-dependent ubiquitin-modiﬁed chromatin (Panier et al.,
2012; Poulsen et al., 2012). Indeed in a study on RNF169 the
Mailand laboratory showed that overexpression of this E3 ligase
stimulates HR efﬁciency while negatively impacting on the levels
of NHEJ. By delaying and limiting the association of 53BP1 to
DSBs while only having a mild effect on BRCA1 accumulation,
the authors suggest that RNF169 might function to limit the use
of NHEJ to repair the DNA lesions, thus channeling the repair
toward the error-free HR pathway.
The data summarized above support a model in which the
DNA damage-dependent ubiquitylation pathway is wired in a
self-limiting circuit involving both positive and negative regula-
tions, which allows histone ubiquitylation near the DNA lesions
but at the same time prevents its excessive spreading to undamaged
regions of the genome. Assembly and disassembly of this circuit
allows for the timely accumulation of genome caretakers at sites
of DNA damage to ensure a correct repair of the lesion.
REGULATION OF RNF168 AT TELOMERES
Unprotected telomeres are perceived and processed by the cell
as sites of DNA damage. This occurs upon attrition of telom-
eric DNA, or when speciﬁc components of shelterin are inhibited
(Palm and de Lange, 2008). TRF2 (telomeric repeat binding fac-
tor 2) and POT1 (protection of telomeres 1) are involved in the
suppression of the two major mammalian DDR pathways, medi-
ated by ATM and ATR, respectively (Denchi and de Lange, 2007).
Deletion of TRF2 from mouse cells leads to ATM activation and
ATM-dependent formation of DNA damage foci at telomeres.
Telomere dysfunction-induced foci (TIFs) contain the same reper-
toire of repair factors detected at DSBs, such as γH2AX, MDC1,
and 53BP1 (Takai et al., 2003). Dysfunctional telomeres are pro-
cessed by the NHEJ pathway resulting in end-to-end fusions (Celli
et al., 2006). Recent ﬁndings from our lab uncovered a two-step
mechanism of end protection mediated by distinct portions of
TRF2. The ﬁrst step requires the TRFH domain, which is involved
in preventing the initial step of theDDRresponse,while the second
step is mediated by a short amino-acid motif in the Hinge domain
of TRF2, termed iDDR (inhibition of DDR) motif, that acts at
the level of RNF168 (Okamoto et al., 2013). Expression of the
iDDR region is sufﬁcient to block the DDR signaling cascade at the
level of RNF168 and prevent chromosome–chromosome fusions
in TRF2-depleted cells. These data suggest that in mammalian
cells repression of unwanted activation of the DDR at telomeres
is achieved in part by inhibiting ubiquitin-dependent signaling at
chromosome ends. The iDDR-dependent inhibition of RNF168
recruitment to dysfunctional telomeres requires the DUB enzyme
BRCC36 and the ubiquitin ligase UBR5. This leads to a model in
which RNF168 recruitment to telomeres is opposed by the con-
certed actionof BRCC36andUBR5 (Figure 5), underscoring again
the importance of correctly regulating the RNF8/RNF168 pathway
in order to ensure the maintenance of genomic stability.
CONTROL OF RNF8/RNF168 DURING VIRAL INFECTION
The DDR is involved in the cellular response to viral infection:
many viruses induce signaling through the same cellular cascade
activated by the DDR, while some parts of the DDR itself are
manipulated by virally encoded proteins in order to prevent detri-
mental outcomes for viral infection (Weitzman et al., 2010, 2011).
Indeed the DDR may have adverse reactions on viral infection
through checkpoint activation, recruitment of repressive factors
and processing of viral DNA. Many viruses interact with the
ubiquitin–proteasome system to block immune response and pro-
mote virus replication (Blanchette and Branton, 2009; Isaacson
and Ploegh, 2009; Randow and Lehner, 2009; Viswanathan et al.,
2010). E3 enzymes confer the majority of the substrate speciﬁcity
to the ubiquitylation cascade; therefore, it is not surprising that
this step is often targeted by viral proteins. One such example
is the viral E3 ligase ICP0, encoded by the herpes simplex virus
type 1 (HSV-1). ICP0 is a RING ﬁnger E3 that induces proteaso-
mal degradation of several cellular proteins including the catalytic
subunit of DNA-dependent protein kinase (DNA-PKcs), com-
ponents of promyelocytic leukemia (PML) nuclear bodies, and
FIGURE 5 | RNF168 inhibition at chromosome ends.TRF2 protects
telomeres from unwanted activation of a DDR both by preventing upstream
ATM activation and by inhibiting RNF168 ubiquitylation at these sites
through recruitment of UBR5 and BRCC36.
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centromeric proteins (Everett et al., 1998, 1999; Parkinson et al.,
1999; Lomonte et al., 2001; Gu and Roizman, 2003; Lomonte
and Morency, 2007). Work from the Weitzman laboratory has
uncovered that ICP0 also targets RNF8 and RNF168, consequently
blocking the DDR pathway at this level to prevent downstream
repair proteins from accumulating at sites of cellular damage (Lil-
ley et al., 2010). ICP0 expression promotes degradation of both
RNF8 and RNF168 independently in a RING-dependent manner.
RNF8 was shown to be targeted by ICP0 through the exploita-
tion of a cellular phosphorylation-based strategy in a more recent
study from the same laboratory (Chaurushiya et al., 2012). ICP0
is phosphorylated by the cellular kinase CK1 on T67, mimicking
the phospho-sites induced on MDC1 during the DDR signaling.
This phospho-site directly binds the RNF8 FHA domain, compet-
ing with the interaction with MDC1, and is responsible for RNF8
degradation.
Given that viruses have evolved to target key convergence points
in cellular pathways, the data described above once again highlight
the importance of the RNF8/RNF168 pathway as a nodal point in
the DDR pathway that needs to be tightly regulated.
RING E3 POLYCOMB PROTEINS AND THE RNF8/RNF168 DSB
RESPONSE PATHWAY
Recent studies have uncovered a function for PcG proteins in the
cellular response to DNA damage that may partially overlap with
that of RNF8/RNF168. PcG proteins are chromatin-associated
proteins that control a variety of cellular processes such as main-
tenance of cellular identity, proper embryonic development, and
cell differentiation and proliferation (Pietersen and van Lohuizen,
2008; Bracken and Helin, 2009; Sauvageau and Sauvageau, 2010;
Surface et al., 2010). Given the well-established role of PcG pro-
teins in gene silencing, it is likely that PcGs contribute to the
transcriptional repression observed at DSBs. Gene silencing at
sites of DNA lesions was shown to be ATM-dependent and
able to spread across kilobases of DNA in cis to the damage
(Cuozzo et al., 2007; O’Hagan et al., 2008; Shanbhag et al., 2010).
An important effector of this phenomenon is H2A ubiquityla-
tion: the levels of uH2A at DSBs are strongly reduced upon
ATM inhibition after DNA damage induction (while no effect
is seen on K63-linked ubiquitin species at the same site) and
this reduction correlates with a reversal of repression of tran-
scription (Shanbhag et al., 2010). It has been demonstrated that
expression of a mutant form of H2A that cannot be monoubiq-
uitylated at K119 partially rescues transcription. A heterodimer
of the E3 ligases BMI1 and RING1B of PRC1 catalyzes his-
tone H2A monoubiquitylation at K119 (Wang et al., 2004; Cao
et al., 2005), promoting gene silencing partly exerted by con-
trolling the RNA polymerase II-mediated elongation phase of
transcription (Stock et al., 2007). Thus, BMI1/RING1B may
be the E3s responsible for the deposition of the H2AK119Ub
repressive mark at sites of DNA lesions. Residues K13-15 of
H2A/H2AX were recently identiﬁed as the target lysines for
RNF8/RNF168 (Mattiroli et al., 2012), thus distinguishing the
RNF8/RNF168 target from that of BMI1/RING1B (K119), sug-
gesting that ubiquitylation of these two sites provides independent
signals in the response to DSBs. In their study, Shanbhag
and colleagues found that co-depletion of RNF8 and RNF168
also lead to a partial rescue of transcription levels at DSBs in
cells treated with an ATM inhibitor after DNA damage induc-
tion. Whether RNF8/RNF168-dependent deposition of uH2A
on K13-15 also directly plays a role in the induction of gene
silencing at DSBs remains to be established (Figure 6). In this
context, it will be important to elucidate the functional cross-
talk between the RNF8/RNF168 ubiquitin pathway and the PcG
proteins to determine if BMI1/RING1B also play a role in coordi-
nating DSB signaling in addition to their hypothesized role in
gene silencing at these sites. Several laboratories have recently
shown that BMI1 and RING1B accumulate at sites of DSBs
generated by IR or laser micro-irradiation, although there are
some discrepancies between the different reports in terms of
the effect of depletion of BMI1 on the recruitment of down-
stream DDR effectors and consequently on DNA repair (Chou
et al., 2010; Facchino et al., 2010; Ismail et al., 2010; Chagraoui
et al., 2011; Ginjala et al., 2011). Further studies will be required
to elucidate the precise role for the PcG proteins in the DDR
pathway.
It will also be interesting to determine whether DUBs have a
role in regulating the activity of PcG E3 ligases in the context
of the DSB response pathway, analogous to their contribution
to the regulation RNF8/RNF168 as described above. The DUBs
USP3 and USP11 are components of the PRC1 complex and
are known to regulate BMI1 and MEL18 (another component
of PRC1) turnover and abundance (Maertens et al., 2010). A novel
PcG complex, polycomb repressive de-ubiquitinase (PR-DUB) has
recently been described in Drosophila and is conserved in humans.
It contains the BRCA1-complex associated protein 1 (BAP1), a
tumor suppressor protein with DUB activity that is involved in de-
ubiquitylation of H2AK119Ub (Ventii et al., 2008; Scheuermann
et al., 2010). In addition, depletion of USP16, which acts as an
antagonist of polycomb-dependent repression of gene expression
(Joo et al., 2007), was shown to prevent the reversal of transcrip-
tional silencing and decrease of uH2A levels observed at DSBs
upon ATM inhibition or cessation of DNA damage. This indicates
that USP16 is responsible for de-ubiquitylation of uH2A at DSBs
(Shanbhag et al., 2010). Whether USP16 targets the products of
FIGURE 6 | Possible role of PcG proteins in the DDR. BMI1/RING1B are
recruited to DSBs, where they are thought to mediate the transcriptional
silencing observed at DSBs via deposition of the K119 mark on H2A-type
histones. RNF8/RNF168 also may contribute to gene repression at DSBs.
BMI1/RING1B may also play additional roles in DDR signaling which remain
to be uncovered.
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RNF8/RNF168- and/or BMI1/RING1B-dependent ubiquitylation
remains to be established.
THE RNF8/RNF168 PATHWAY AND SUMO-DEPENDENT
SIGNALING
Increasing evidence supports an important role for sumoylation
in promoting the response to DSBs (reviewed in Bekker-Jensen
and Mailand, 2011; Praefcke et al., 2012). Similarly to ubiquity-
lation, sumoylation is a process through which a SUMO moiety
is covalently attached to a substrate protein. SUMO1, SUMO2/3,
and the SUMO E3 ligases PIAS1 and PIAS4 accumulate at DSBs;
PIAS1 and PIAS4 were shown to be responsible for sumoylation
of 53BP1 as well as BRCA1 and their consequent accrual and/or
retention at IRIFs (Galanty et al., 2009; Morris et al., 2009). Fur-
thermore, a recent study from the Mailand group demonstrated
that sumoylation of HERC2 and RNF168 by PIAS4 promotes
ubiquitin-mediated protein assembly at DSB-surrounding chro-
matin, indicating that sumoylation is involved in regulation of the
RNF8/RNF168 pathway (Danielsen et al., 2012). RNF8 or RNF168
depletion does not prevent PIAS1/4 accumulation at DSBs, but it
does reduce the accrual of SUMO1 and SUMO2/3 to the damage
sites. Thus the mechanism through which PIAS1 and PIAS4 are
recruited toDSBs is independent of RNF8/RNF168,while presence
of sumoylated protein species at damaged chromatin is down-
stream of RNF8/RNF168, likely because these ligases are in ﬁrst
instance required for recruitment of target proteins such as BRCA1
and 53BP1, which are subsequently sumoylated.
An additional link between the RNF8/RNF168 pathway and
sumoylation is provided by the ﬁndings that the SUMO-targeted
ubiquitin ligase (STUbL) RNF4, which is also recruited to DSBs,
generates hybrid SUMO-ubiquitin chains at sites of DNA lesions
which are critical for the recruitment of RAP80 and BRCA1 to the
damaged chromatin and for consequent DNA repair (Prudden
et al., 2007; Galanty et al., 2012; Guzzo et al., 2012). RNF4 is not
required for RNF8/RNF168 recruitment to DSBs, but its deple-
tion leads to delayed clearance of RNF8, RNF168, and 53BP1 from
DSB foci and, strikingly, to a signiﬁcant decrease in K63-linked
ubiquitin chains that are deposited at DSBs (Yin et al., 2012). One
possibility is that the mixed SUMO-ubiquitin chains generated
by RNF4 are required to amplify the ubiquitin signal deposited
by RNF8/RNF168. Further studies are required to understand
the exact role of RNF4 at DSBs and how the complex inter-
play between RNF8/RNF168-dependent ubiquitin signaling and
SUMO signaling at sites of DNA lesions contributes to DNA repair
and cell survival.
CONCLUDING REMARKS AND FUTURE PERSPECTIVES
The DDR and repair pathways are of vital importance to cor-
rect damages in the genome and ensure genomic stability. A
wide variety of human genome instability syndromes exist whose
underlying cause is the inactivation of DDR and repair genes
(reviewed in Kerzendorfer and O’Driscoll, 2009). A paradigm
for such syndromes is ataxia-telangiectasia (A-T), caused by a bi-
allelic mutation in ATM (Savitsky et al., 1995). A-T symptoms
are progressive neurodegeneration, immune dysfunction, hyper-
sensitivity to IR, and marked cancer predisposition (Lavin and
Shiloh, 1997). Inaccurate repair of DSBs can lead to chromosomal
rearrangements that promote tumorigenesis (Jeggo and Lobrich,
2007). The present review focused on themultiplicity of regulation
mechanisms that have evolved to tightly control one impor-
tant nodule of the DDR signaling cascade, the RNF8/RNF168
pathway. Mutations of RNF168 are associated with the RID-
DLE syndrome, which is characterized by defects in repairing
DSBs (Stewart et al., 2009). It will be important to determine if
RNF8/RNF168 activity opposes tumor formation and whether
the DDR ubiquitylation pathway could represent a novel thera-
peutic target for cancer treatment. The multiple regulations of the
RNF8/RNF168 pathway represent potential therapeutic targets,
for example, in situations in which compromised ubiquitylation
activity has a radioprotective function in cancer cells. In these cases
the inhibition of speciﬁc DUBs may represent a viable therapeutic
strategy.
Polycomb group-mediated repression of tumor suppressor
genes is causally linked to cancer development (Bracken andHelin,
2009). The recent ﬁnding that PcG proteins may be involved in
the response to DSBs provides an incentive to develop small-
molecule inhibitors of PcG in order to treat cancer in combination
with standard treatment strategies such as chemotherapeutics or
radiotherapy, which induce DNA damage.
ACKNOWLEDGMENTS
WethankLyndaGroocock, Stephanie Papp, andDaniele Fachinetti
for helpful discussions and critical reading of the manuscript.
Work in the authors’ laboratory is supported by the Pew Schol-
ars Award, the Novartis Advanced Discovery Institute, and NIH
AG038677 to Eros Lazzerini Denchi.
REFERENCES
Acs, K., Luijsterburg, M. S., Ackermann,
L., Salomons, F. A., Hoppe, T., Dan-
tuma, N. P., et al. (2011). The AAA-
ATPase VCP/p97 promotes 53BP1
recruitment by removing L3MBTL1
from DNA double-strand breaks.
Nat. Struct. Mol. Biol. 18, 1345–1350.
doi: 10.1038/nsmb.2188
Bakkenist, C. J., and Kastan, M. B.
(2003). DNA damage activates ATM
through intermolecular autophos-
phorylation and dimer dissocia-
tion. Nature 421, 499–506. doi:
10.1038/nsmb.2188
Bekker-Jensen, S., Lukas, C., Kitagawa,
R., Melander, F., Kastan, M. B.,
Bartek, J., et al. (2006). Spatial orga-
nization of the mammalian genome
surveillancemachinery in response to
DNA strand breaks. J. Cell Biol. 173,
195–206. doi: 10.1038/nature01368
Bekker-Jensen, S., and Mailand, N.
(2011). The ubiquitin- and SUMO-
dependent signaling response to
DNA double-strand breaks. FEBS
Lett. 585, 2914–2919. doi: 10.1083/
jcb.200510130
Bekker-Jensen, S., Rendtlew Danielsen,
J., Fugger, K., Gromova, I., Nerstedt,
A., Lukas, C., et al. (2010). HERC2
coordinates ubiquitin-dependent
assembly of DNA repair factors on
damaged chromosomes. Nat. Cell
Biol. 12, 80–86. doi: 10.1016/j.febslet.
2011.05.056
Blanchette, P., and Branton, P.
E. (2009). Manipulation of the
ubiquitin-proteasome pathway by
small DNA tumor viruses. Virology
384, 317–323. doi: 10.1038/ncb2008
Botuyan, M. V., Lee, J., Ward,
I. M., Kim, J. E., Thompson,
J. R., Chen, J., et al. (2006).
Structural basis for the methylation
state-speciﬁc recognition of histone
H4-K20 by 53BP1 and Crb2 in DNA
repair. Cell 127, 1361–1373. doi:
10.1016/j.virol.2008.10.005
Bouwman, P., Aly, A., Escandell, J. M.,
Pieterse, M., Bartkova, J., van der
Gulden, H., et al. (2010). 53BP1
loss rescues BRCA1 deﬁciency and
is associated with triple-negative and
BRCA-mutated breast cancers. Nat.
Struct. Mol. Biol. 17, 688–695. doi:
10.1016/j.cell.2006.10.043
Bracken, A. P., and Helin, K. (2009).
Polycomb group proteins: naviga-
tors of lineage pathways led astray in
www.frontiersin.org July 2013 | Volume 4 | Article 128 | 9
“fgene-04-00128” — 2013/11/16 — 18:07 — page 10 — #10
Bartocci and Denchi Regulation of RNF8/168 at DNA damage sites
cancer. Nat. Rev. Cancer 9, 773–784.
doi: 10.1038/nsmb.1831
Bunting, S. F., Callén, E., Wong,
N., Chen, H. T., Polato, F.,
Gunn, A., et al. (2010). 53BP1
inhibits homologous recombination
in Brca1-deﬁcient cells by blocking
resection of DNA breaks. Cell 141,
243–254. doi: 10.1038/nrc2736
Burma, S., Chen, B. P., Murphy, M.,
Kurimasa, A., and Chen, D. J. (2001).
ATM phosphorylates histone H2AX
in response to DNA double-strand
breaks. J. Biol. Chem. 276, 42462–
42467. doi: 10.1074/jbc.C100466200
Caestecker, K. W., and Van de Walle,
G. R. (2013). The role of BRCA1 in
DNA double-strand repair: past and
present. Exp. Cell Res. 319, 575–587.
doi: 10.1074/jbc.C100466200
Cao, R., Tsukada, Y., and Zhang, Y.
(2005). Role of Bmi-1 and Ring1A
in H2A ubiquitylation and Hox gene
silencing. Mol. Cell 20, 845–854. doi:
10.1016/j.yexcr.2012.11.013
Celli, G. B., Denchi, E. L., and
de Lange, T. (2006). Ku70 stimu-
lates fusion of dysfunctional telom-
eres yet protects chromosome ends
from homologous recombination.
Nat. Cell Biol. 8, 885–890. doi:
10.1016/j.molcel.2005.12.002
Chagraoui, J., Hebert, J., Girard, S., and
Sauvageau, G. (2011). An anticlas-
togenic function for the polycomb
group gene Bmi1. Proc. Natl. Acad.
Sci. U.S.A. 108, 5284–5289. doi:
10.1038/ncb1444
Chapman, J. R., and Jackson, S. P.
(2008). Phospho-dependent inter-
actions between NBS1 and MDC1
mediate chromatin retention of the
MRN complex at sites of DNA dam-
age. EMBO Rep. 9, 795–801. doi:
10.1073/pnas.1014263108
Chaurushiya, M. S., Lilley, C. E., Asla-
nian, A., Meisenhelder, J., Scott,
D. C., Landry, S., et al. (2012).
Viral E3 ubiquitin ligase-mediated
degradation of a cellular E3: viral
mimicry of a cellular phosphoryla-
tion mark targets the RNF8 FHA
domain. Mol. Cell 46, 79–90. doi:
10.1038/embor.2008.103
Chou, D. M., Adamson, B., Dephoure,
N. E., Tan, X., Nottke, A. C.,
Hurov, K. E., et al. (2010). A
chromatin localization screen reveals
poly (ADP ribose)-regulated recruit-
ment of the repressive polycomb
and NuRD complexes to sites of
DNA damage. Proc. Natl. Acad.
Sci. U.S.A. 107, 18475–18480. doi:
10.1016/j.molcel.2012.02.004
Ciechanover, A., Elias, S., Heller,
H., and Hershko, A. (1982).
“Covalent afﬁnity” puriﬁcation
of ubiquitin-activating enzyme. J.
Biol. Chem. 257, 2537–2542. doi:
10.1073/pnas.1012946107
Clancy, J. L., Henderson, M. J., Rus-
sell, A. J., Anderson, D. W., Bova,
R. J., Campbell, I. G., et al. (2003).
EDD, the human orthologue of the
hyperplastic discs tumour suppressor
gene, is ampliﬁed and overexpressed
in cancer. Oncogene 22, 5070–5081.
doi: 10.1038/sj.onc.1206775
Coleman, K. A., and Greenberg, R. A.
(2011). The BRCA1–RAP80 complex
regulatesDNA repairmechanismuti-
lization by restricting end resection.
J. Biol. Chem. 286, 13669–13680. doi:
10.1038/sj.onc.1206775
Cuozzo, C., Porcellini, A., Angrisano,
T., Morano, A., Lee, B., Di Pardo,
A., et al. (2007). DNA damage,
homology-directed repair, and DNA
methylation. PLoS Genet. 3:e110. doi:
10.1371/journal.pgen.0030110
Danielsen, J. R., Povlsen, L. K., Villum-
sen, B. H., Streicher, W., Nilsson, J.,
Wikström, M., et al. (2012). DNA
damage-inducible SUMOylation of
HERC2 promotes RNF8 binding via
a novel SUMO-binding Zinc ﬁn-
ger. J. Cell Biol. 197, 179–187. doi:
10.1371/journal.pgen.0030110
Delacote, F., and Lopez, B. S.
(2008). Importance of the cell cycle
phase for the choice of the appro-
priate DSB repair pathway, for
genome stability maintenance: the
trans-S double-strand break repair
model. Cell Cycle 7, 33–38. doi:
10.1128/MCB.23.16.5706-5715.2003
Denchi, E. L., and de Lange, T. (2007).
Protection of telomeres through
independent control of ATM and
ATR by TRF2 and POT1. Nature 448,
1068–1071. doi: 10.4161/cc.7.1.5149
Deshaies, R. J., and Joazeiro, C. A.
(2009). RING domain E3 ubiqui-
tin ligases. Annu. Rev. Biochem. 78,
399–434. doi: 10.1038/nature06065
Diﬁlippantonio, S., Gapud, E., Wong,
N., Huang, C. Y., Mahowald, G.,
Chen, H. T., et al. (2008). 53BP1
facilitates long-range DNA end-
joining duringV(D)J recombination.
Nature 456, 529–533. doi: 10.1146/
annurev.biochem.78.101807.093809
Dimitrova, N., Chen, Y. C., Spector, D.
L., and de Lange, T. (2008). 53BP1
promotes non-homologous end join-
ing of telomeres by increasing chro-
matin mobility. Nature 456, 524–528.
doi: 10.1038/nature07476
Doil, C., Mailand, N., Bekker-Jensen,
S., Menard, P., Larsen, D. H., Pep-
perkok, R., et al. (2009). RNF168
binds and ampliﬁes ubiquitin con-
jugates on damaged chromosomes
to allow accumulation of repair
proteins. Cell 136, 435–446. doi:
10.1038/nature07433
Everett, R. D., Earnshaw, W. C., Find-
lay, J., and Lomonte, P. (1999).
Speciﬁc destruction of kinetochore
protein CENP-C and disruption of
cell division by herpes simplex virus
immediate-early protein Vmw110.
EMBO J. 18, 1526–1538. doi:
10.1016/j.cell.2008.12.041
Everett, R. D., Freemont, P., Saitoh, H.,
Dasso, M., Orr, A., Kathoria, M.,
et al. (1998). The disruption of ND10
during herpes simplex virus infec-
tion correlateswith theVmw110- and
proteasome-dependent loss of several
PML isoforms. J. Virol. 72, 6581–
6591. doi: 10.1093/emboj/18.6.1526
Facchino, S., Abdouh, M., Cha-
too, W., and Bernier, G. (2010).
BMI1 confers radioresistance to nor-
mal and cancerous neural stem
cells through recruitment of the
DNA damage response machinery.
J. Neurosci. 30, 10096–10111. doi:
10.1523/JNEUROSCI.1634-10.2010
Galanty, Y., Belotserkovskaya, R.,
Coates, J., and Jackson, S. P.
(2012). RNF4, a SUMO-targeted
ubiquitin E3 ligase, promotes
DNA double-strand break repair.
Genes Dev. 26, 1179–1195. doi:
10.1523/JNEUROSCI.1634-10.2010
Galanty, Y., Belotserkovskaya, R.,
Coates, J., Polo, S., Miller, K. M.,
and Jackson, S. P. (2009). Mammalian
SUMO E3-ligases PIAS1 and PIAS4
promote responses to DNA double-
strand breaks. Nature 462, 935–939.
doi: 10.1101/gad.188284.112
Ginjala, V., Nacerddine, K., Kulkarni,
A., Oza, J., Hill, S. J., Yao, M.,
et al. (2011). BMI1 is recruited to
DNA breaks and contributes to DNA
damage-inducedH2Aubiquitination
and repair. Mol. Cell. Biol. 31, 1972–
1982. doi: 10.1038/nature08657
Gu, H., and Roizman, B. (2003).
The degradation of promyelocytic
leukemia and Sp100 proteins by
herpes simplex virus 1 is medi-
ated by the ubiquitin-conjugating
enzyme UbcH5a. Proc. Natl. Acad.
Sci. U.S.A. 100, 8963–8968. doi:
10.1128/MCB.00981-10
Gudjonsson, T., Altmeyer, M., Savic,
V., Toledo, L., Dinant, C., Grøfte,
M., et al. (2012). TRIP12 and UBR5
suppress spreading of chromatin
ubiquitylation at damaged chromo-
somes. Cell 150, 697–709. doi:
10.1073/pnas.1533420100
Guzzo, C. M., Berndsen, C. E., Zhu,
J., Gupta, V., Datta, A., Greenberg,
R. A., et al. (2012). RNF4-dependent
hybrid SUMO-ubiquitin chains are
signals for RAP80 and thereby medi-
ate the recruitment of BRCA1 to sites
of DNA damage. Sci. Signal. 5, ra88.
doi: 10.1126/scisignal.2003485
Hashizume, R., Fukuda, M., Maeda, I.,
Nishikawa, H., Oyake, D., Yabuki, Y.,
et al. (2001). The RING heterodimer
BRCA1-BARD1 is a ubiquitin lig-
ase inactivated by a breast cancer-
derived mutation. J. Biol. Chem. 276,
14537–14540. doi: 10.1126/scisig-
nal.2003485
Hershko, A., Heller, H., Elias, S.,
and Ciechanover, A. (1983). Com-
ponents of ubiquitin-protein ligase
system. Resolution, afﬁnity puriﬁca-
tion, and role in protein breakdown.
J. Biol. Chem. 258, 8206–8214. doi:
10.1074/jbc.C000881200
Hu, Y., Scully, R., Sobhian, B., Xie,
A., Shestakova, E., and Livingston,
D. M. (2011). RAP80-directed tuning
of BRCA1 homologous recombina-
tion function at ionizing radiation-
induced nuclear foci. Genes Dev. 25,
685–700. doi: 10.1101/gad.2011011
Huen, M. S., Grant, R, Manke, I.,
Minn, K., Yu, X., Yaffe, M. B.,
et al. (2007). RNF8 transduces the
DNA-damage signal via histone ubiq-
uitylation and checkpoint protein
assembly. Cell 131, 901–914. doi:
10.1101/gad.2011011
Huen, M. S., Sy, S. M., and Chen, J.
(2010). BRCA1 and its toolbox for
the maintenance of genome integrity.
Nat. Rev. Mol. Cell Biol. 11, 138–148.
doi: 10.1016/j.cell.2007.09.041
Isaacson, M. K., and Ploegh, H. L.
(2009). Ubiquitination, ubiquitin-
like modiﬁers, and deubiquitina-
tion in viral infection. Cell Host
Microbe 5, 559–570. doi: 10.1038/
nrm2831
Ismail, I. H., Andrin, C., McDon-
ald, D., and Hendzel, M. J. (2010).
BMI1-mediated histone ubiquityla-
tion promotes DNA double-strand
break repair. J. Cell Biol. 191, 45–60.
doi: 10.1016/j.chom.2009.05.012
Jeggo, P. A., and Lobrich, M.
(2007). DNA double-strand breaks:
their cellular and clinical impact?
Oncogene 26, 7717–7719. doi:
10.1083/jcb.201003034
Johnson, E. S. (2002). Ubiquitin
branches out. Nat. Cell Biol. 4, E295–
E298. doi: 10.1038/sj.onc.1210868
Joo, H. Y., Zhai, L., Yang, C., Nie, S.,
Erdjument-Bromage, H., Tempst, P.,
et al. (2007). Regulation of cell cycle
progression and gene expression by
H2A deubiquitination. Nature 449,
1068–1072. doi: 10.1038/ncb1202-
e295
Kerzendorfer, C., and O’Driscoll,
M. (2009). Human DNA damage
response and repair deﬁciency syn-
dromes: linking genomic instability
and cell cycle checkpoint proﬁciency.
DNA Repair 8, 1139–1152. doi:
10.1038/nature06256
Frontiers in Genetics | Cancer Genetics July 2013 | Volume 4 | Article 128 | 10
“fgene-04-00128” — 2013/11/16 — 18:07 — page 11 — #11
Bartocci and Denchi Regulation of RNF8/168 at DNA damage sites
Kim, H., Chen, J., and Yu, X.
(2007). Ubiquitin-binding protein
RAP80 mediates BRCA1-dependent
DNA damage response. Science
316, 1202–1205. doi: 10.1016/
j.dnarep.2009.04.018
Kolas, N. K., Chapman, J. R., Nakada, S.,
Ylanko, J., Chahwan, R., Sweeney, F.
D., et al. (2007). Orchestration of the
DNA-damage response by the RNF8
ubiquitin ligase. Science 318, 1637–
1640. doi: 10.1126/science.1139621
Lavin, M. F., and Shiloh, Y. (1997). The
genetic defect in ataxia-telangiec-
tasia. Annu. Rev. Immunol. 15, 177–
202. doi: 10.1126/science.1150034
Lieber, M. R. (2008). The mechanism
of human nonhomologous DNA end
joining. J. Biol. Chem. 283, 1–5. doi:
10.1146/annurev.immunol.15.1.177
Lilley, C. E., Chaurushiya,M. S., Boutell,
C., Landry, S., Suh, J., Panier, S.,
et al. (2010). A viral E3 ligase targets
RNF8 and RNF168 to control his-
tone ubiquitination and DNA dam-
age responses. EMBO J. 29, 943–955.
doi: 10.1074/jbc.R700039200
Lipkowitz, S., and Weissman, A. M.
(2011). RINGs of good and evil:
RING ﬁnger ubiquitin ligases at the
crossroads of tumour suppression
and oncogenesis. Nat. Rev. Can-
cer 11, 629–643. doi: 10.1038/
emboj.2009.400
Lomonte, P., and Morency, E. (2007).
Centromeric protein CENP-B pro-
teasomal degradation induced by the
viral protein ICP0. FEBS Lett. 581,
658–662. doi: 10.1038/nrc3120
Lomonte, P., Sullivan, K. F., and
Everett, R. D. (2001). Degrada-
tion of nucleosome-associated cen-
tromeric histone H3-like protein
CENP-A induced by herpes sim-
plex virus type 1 protein ICP0. J.
Biol. Chem. 276, 5829–5835. doi:
10.1016/j.febslet.2007.01.027
Luijsterburg, M. S., Acs, K., Acker-
mann, L., Wiegant, W. W., Bekker-
Jensen, S., Larsen, D. H., et al.
(2012). A new non-catalytic role
for ubiquitin ligase RNF8 in unfold-
ing higher-order chromatin struc-
ture. EMBO J. 31, 2511–2527. doi:
10.1074/jbc.M008547200
Luijsterburg, M. S., and van Attikum,
H. (2012). Close encounters of the
RNF8th kind: when chromatin meets
DNA repair. Curr. Opin. Cell Biol.
24, 439–447. doi: 10.1038/emboj.
2012.104
Maertens, G. N., El Messaoudi-Aubert,
S., Elderkin, S., Hiom, K., and Peters,
G. (2010). Ubiquitin-speciﬁc pro-
teases 7 and 11 modulate polycomb
regulation of the INK4a tumour sup-
pressor. EMBO J. 29, 2553–2563. doi:
10.1016/j.ceb.2012.03.008
Mailand, N., Bekker-Jensen, S., Faus-
trup, H., Melander, F., Bartek, J.,
Lukas, C., et al. (2007). RNF8 ubiq-
uitylates histones at DNA double-
strand breaks and promotes assembly
of repair proteins. Cell 131, 887–900.
doi: 10.1038/emboj.2010.129
Mallette, F. A., Mattiroli, F., Cui,
G., Young, L. C., Hendzel, M.
J., Mer, G., et al. (2012). RNF8-
and RNF168-dependent degradation
of KDM4A/JMJD2A triggers 53BP1
recruitment to DNA damage sites.
EMBO J. 31, 1865–1878. doi:
10.1016/j.cell.2007.09.040
Mattiroli, F., Vissers, J. H., van Dijk, W.
J., Ikpa, P.,Citterio, E.,Vermeulen,W.,
et al. (2012). RNF168 ubiquitinates
K13-15 on H2A/H2AX to drive DNA
damage signaling. Cell 150, 1182–
1195. doi: 10.1038/emboj.2012.47
Meerang, M., Ritz, D., Paliwal, S., Gara-
jova, Z., Bosshard, M., Mailand, N.,
et al. (2011). The ubiquitin-selective
segregase VCP/p97 orchestrates the
response to DNA double-strand
breaks. Nat. Cell Biol. 13, 1376–
1382. doi: 10.1016/j.cell.2012.08.
005
Melander, F., Bekker-Jensen, S., Falck,
J., Bartek, J., Mailand, N., and
Lukas, J. (2008). Phosphorylation
of SDT repeats in the MDC1 N ter-
minus triggers retention of NBS1
at the DNA damage-modiﬁed chro-
matin. J. Cell Biol. 181, 213–216. doi:
10.1038/ncb2367
Morris, J. R., Boutell, C., Kep-
pler, M., Densham, R., Weekes,
D., Alamshah, A., et al. (2009).
The SUMO modiﬁcation pathway is
involved in the BRCA1 response to
genotoxic stress. Nature 462, 886–
890. doi: 10.1083/jcb.200708210
Moynahan, M. E., Chiu, J. W., Koller,
B. H., and Jasin, M. (1999). Brca1
controls homology-directed DNA
repair. Mol. Cell 4, 511–518. doi:
10.1038/nature08593
Nakada, S., Tai, I., Panier, S., Al-
Hakim, A., Iemura, S., Juang, Y.
C., et al. (2010). Non-canonical inhi-
bition of DNA damage-dependent
ubiquitination by OTUB1. Nature
466, 941–946. doi: 10.1016/S1097-
2765(00)80202-6
Nakamura, K., Sakai, W., Kawamoto,
T., Bree, R. T., Lowndes, N. F.,
Takeda, S., et al. (2006). Genetic dis-
section of vertebrate 53BP1: a major
role in non-homologous end join-
ing of DNA double strand breaks.
DNA Repair 5, 741–749. doi:
10.1038/nature09297
Nicassio, F., Corrado, N., Vissers, J. H.,
Areces, L. B., Bergink, S., Marteijn,
J. A., et al. (2007). Human USP3 is
a chromatin modiﬁer required for S
phase progression and genome stabil-
ity. Curr. Biol. 17, 1972–1977. doi:
10.1016/j.dnarep.2006.03.008
Nijman, S. M., Luna-Vargas, M.
P., Velds, A., Brummelkamp, T.
R., Dirac, A. M., Sixma, T. K.,
et al. (2005). A genomic and func-
tional inventory of deubiquitinating
enzymes. Cell 123, 773–786. doi:
10.1016/j.cub.2007.10.034
O’Brien, P. M., Davies, M. J., Scurry,
J. P., Smith, A. N., Barton, C.
A., Henderson, M. J., et al. (2008).
The E3 ubiquitin ligase EDD is an
adverse prognostic factor for serous
epithelial ovarian cancer and mod-
ulates cisplatin resistance in vitro.
Br. J. Cancer 98, 1085–1093. doi:
10.1016/j.cell.2005.11.007
O’Hagan, H. M., Mohammad, H.
P., and Baylin, S. B. (2008). Dou-
ble strand breaks can initiate gene
silencing and SIRT1-dependent onset
of DNA methylation in an exoge-
nous promoter CpG island. PLoS
Genet. 4:e1000155. doi: 10.1371/
journal.pgen.1000155
Okamoto, K., Bartocci, C., Ouzounov,
I., Diedrich, J. K., Yates, J. R. III.,
and Denchi, E. L. (2013). A two-
step mechanism for TRF2-mediated
chromosome-end protection. Nature
494, 502–505. doi: 10.1371/jour-
nal.pgen.1000155
Oliner, J. D., Kinzler, K. W., Meltzer,
P. S., George, D. L., and Vogelstein,
B. (1992). Ampliﬁcation of a gene
encoding a p53-associated protein in
human sarcomas. Nature 358, 80–83.
doi: 10.1038/nature11873
Palm, W., and de Lange, T. (2008). How
shelterin protects mammalian telom-
eres. Annu. Rev. Genet. 42, 301–334.
doi: 10.1038/358080a0
Panier, S., and Durocher, D. (2009).
Regulatory ubiquitylation in
response to DNA double-strand
breaks. DNA Repair 8, 436–443. doi:
10.1146/annurev.genet.41.110306.
130350
Panier, S., Ichijima, Y., Fradet-Turcotte,
A., Leung, C. C., Kaustov, L., Arrow-
smith, C. H., et al. (2012). Tandem
protein interaction modules organize
the ubiquitin-dependent response to
DNA double-strand breaks. Mol. Cell
47, 383–395. doi: 10.1016/j.dnarep.
2009.01.013
Parkinson, J., Lees-Miller, S. P., and
Everett, R. D. (1999). Herpes simplex
virus type 1 immediate-early protein
vmw110 induces the proteasome-
dependent degradation of the cat-
alytic subunit of DNA-dependent
protein kinase. J. Virol. 73, 650–657.
doi: 10.1016/j.molcel.2012.05.045
Pietersen, A. M., and van Lohuizen,
M. (2008). Stem cell regulation
by polycomb repressors: postpon-
ing commitment. 20, 201–207. doi:
10.1016/j.ceb.2008.01.004
Pinato, S., Scandiuzzi, C., Arnaudo, N.,
Citterio, E., Gaudino, G., Penengo,
L., et al. (2009). RNF168, a new
RING ﬁnger, MIU-containing pro-
tein that modiﬁes chromatin by
ubiquitination of histones H2A and
H2AX. BMC Mol. Biol. 10:55. doi:
10.1186/1471-2199-10-55
Poulsen, M., Lukas, C., Lukas, J.,
Bekker-Jensen, S., and Mailand,
N. (2012). Human RNF169 is a
negative regulator of the ubiquitin-
dependent response to DNA double-
strand breaks. J. Cell Biol. 197,
189–199. doi: 10.1186/1471-2199-
10-55
Praefcke, G. J., Hofmann, K., and
Dohmen, R. J. (2012). SUMO
playing tag with ubiquitin. Trends
Biochem. Sci. 37, 23–31. doi:
10.1083/jcb.201109100
Prudden, J., Pebernard, S., Raffa, G.,
Slavin, D. A., Perry, J. J., Tainer,
J. A., et al. (2007). SUMO-targeted
ubiquitin ligases in genome stabil-
ity. EMBO J. 26, 4089–4101. doi:
10.1016/j.tibs.2011.09.002
Randow, F., and Lehner, P. J.
(2009). Viral avoidance and exploita-
tion of the ubiquitin system. Nat.
Cell Biol. 11, 527–534. doi:
10.1038/sj.emboj.7601838
Rogakou, E. P., Pilch, D. R., Orr, A. H.,
Ivanova, V. S., and Bonner, W. M.
(1998). DNA double-stranded breaks
induce histone H2AX phosphoryla-
tion on serine 139. J. Biol. Chem. 273,
5858–5868. doi: 10.1038/ncb0509-
527
Ruffner, H., Joazeiro, C. A., Hemmati,
D., Hunter, T., and Verma, I. M.
(2001). Cancer-predisposing muta-
tions within the RING domain of
BRCA1: loss of ubiquitin protein
ligase activity and protection from
radiation hypersensitivity. Proc. Natl.
Acad. Sci. U.S.A. 98, 5134–5139. doi:
10.1074/jbc.273.10.5858
Sanders, S. L., Portoso, M., Mata,
J., Bähler, J., Allshire, R. C., and
Kouzarides, T. (2004). Methylation
of histone H4 lysine 20 controls
recruitment of Crb2 to sites of DNA
damage. Cell 119, 603–614. doi:
10.1073/pnas.081068398
Sauvageau, M., and Sauvageau, G.
(2010). Polycomb group proteins:
multi-faceted regulators of somatic
stem cells and cancer. Cell Stem
Cell 7, 299–313. doi: 10.1016/
j.stem.2010.08.002
Savitsky,K., Bar-Shira,A.,Gilad, S., Rot-
man, G., Ziv, Y., Vanagaite, L., et al.
(1995). A single ataxia telangiectasia
gene with a product similar to PI-3
www.frontiersin.org July 2013 | Volume 4 | Article 128 | 11
“fgene-04-00128” — 2013/11/16 — 18:07 — page 12 — #12
Bartocci and Denchi Regulation of RNF8/168 at DNA damage sites
kinase. Science 268, 1749–1753. doi:
10.1016/j.stem.2010.08.002
Scheuermann, J. C., de Ayala Alonso,
A. G., Oktaba, K., Ly-Hartig, N.,
McGinty, R. K., Fraterman, S., et al.
(2010). Histone H2A deubiquitinase
activity of the polycomb repressive
complex PR-DUB. Nature 465, 243–
247. doi: 10.1126/science.7792600
Shanbhag, N. M., Rafalska-Metcalf, I.
U., Balane-Bolivar, C., Janicki, S. M.,
and Greenberg, R. A. (2010). ATM-
dependent chromatin changes silence
transcription in cis to DNA double-
strand breaks. Cell 141, 970–981. doi:
10.1038/nature08966
Shao, G., Lilli, D. R., Patterson-
Fortin, J., Coleman, K. A., Mor-
rissey, D. E., Greenberg, R.
A., et al. (2009). The Rap80-
BRCC36 de-ubiquitinating enzyme
complex antagonizes RNF8-Ubc13-
dependent ubiquitination events at
DNA double strand breaks. Proc.
Natl. Acad. Sci. U.S.A. 106, 3166–
3171. doi: 10.1016/j.cell.2010.04.
038
Smeenk, G., Wiegant, W. W.,
Marteijn, J. A., Luijsterburg, M.
S., Sroczynski, N., Costelloe, T.,
et al. (2012). Poly(ADP-ribosyl)ation
links the chromatin remodeler
SMARCA5/SNF2H to RNF168-
dependent DNA damage signaling.
J. Cell Sci. 126(Pt 4), 889–903. doi:
10.1073/pnas.0807485106
Sobhian, B., Shao, G., Lilli, D. R., Cul-
hane, A. C., Moreau, L. A., Xia, B.,
et al. (2007). RAP80 targets BRCA1 to
speciﬁc ubiquitin structures at DNA
damage sites. Science 316, 1198–1202.
doi: 10.1126/science.1139516
Soria, G., Polo, S. E., and Almouzni,
G. (2012). Prime, repair, restore: the
active role of chromatin in the DNA
damage response. Mol. Cell 46, 722–
734. doi: 10.1126/science.1139516
Sowa, M. E., Bennett, E. J., Gygi,
S. P., and Harper, J. W. (2009).
Deﬁning the human deubiquitinat-
ing enzyme interaction landscape.
Cell 138, 389–403. doi: 10.1016/
j.molcel.2012.06.002
Spycher, C., Miller, E. S., Townsend,
K., Pavic, L., Morrice, N. A.,
and Janscak, P. (2008). Constitu-
tive phosphorylation of MDC1 phys-
ically links the MRE11-RAD50-NBS1
complex to damaged chromatin.
J. Cell Biol. 181, 227–240. doi:
10.1016/j.cell.2009.04.042
Stewart, G. S., Panier, S., Townsend, K.,
Al-Hakim, A. K., Kolas, N. K., Miller,
E. S., et al. (2009). The RIDDLE syn-
drome protein mediates a ubiquitin-
dependent signaling cascade at sites
of DNA damage. Cell 136, 420–434.
doi: 10.1083/jcb.200709008
Stock, J. K., Giadrossi, S., Casanova,
M., Brookes, E., Vidal, M.,
Koseki, H., et al. (2007). Ring1-
mediated ubiquitination of H2A
restrains poised RNA polymerase II
at bivalent genes in mouse ES cells.
Nat. Cell Biol. 9, 1428–1435. doi:
10.1016/j.cell.2008.12.042
Stucki, M., Clapperton, J. A., Moham-
mad, D., Yaffe, M. B., Smerdon,
S. J., and Jackson, S. P. (2005).
MDC1 directly binds phosphory-
lated histone H2AX to regulate cellu-
lar responses to DNA double-strand
breaks. Cell 123, 1213–1226. doi:
10.1038/ncb1663
Sun, L., and Chen, Z. J. (2004).
The novel functions of ubiquitina-
tion in signaling. Curr. Opin. Cell
Biol. 16, 119–126. doi: 10.1016/
j.cell.2005.09.038
Surface, L. E., Thornton, S. R., and
Boyer, L. A. (2010). Polycomb group
proteins set the stage for early lineage
commitment. Cell Stem Cell 7, 288–
298. doi: 10.1016/j.ceb.2004.02.005
Takai, H., Smogorzewska, A., and
de Lange, T. (2003). DNA dam-
age foci at dysfunctional telomeres.
Curr. Biol. 13, 1549–1556. doi:
10.1016/j.stem.2010.08.004
Ventii, K. H., Devi, N. S., Friedrich, K.
L., Chernova, T. A., Tighiouart, M.,
Van Meir, E. G., et al. (2008). BRCA1-
associated protein-1 is a tumor
suppressor that requires deubiquiti-
nating activity and nuclear localiza-
tion. Cancer Res. 68, 6953–6962. doi:
10.1016/S0960-9822(03)00542-6
Viswanathan, K., Fruh, K., and DeFil-
ippis, V. (2010). Viral hijacking
of the host ubiquitin system to
evade interferon responses. Curr.
Opin. Microbiol. 13, 517–523. doi:
10.1158/0008-5472.CAN-08-0365
Wade, M., Wang, Y. V., and Wahl,
G. M. (2010). The p53 orchestra:
Mdm2 and Mdmx set the tone.
Trends Cell Biol. 20, 299–309. doi:
10.1016/j.mib.2010.05.012
Wang, B., and Elledge, S. J. (2007).
Ubc13/Rnf8 ubiquitin ligases con-
trol foci formation of the Rap80/
Abraxas/Brca1/Brcc36 complex in
response to DNA damage. Proc. Natl.
Acad. Sci. U.S.A. 104, 20759–20763.
doi: 10.1016/j.tcb.2010.01.009
Wang, B., Matsuoka, S., Ballif, B.
A., Zhang, D., Smogorzewska, A.,
Gygi, S. P., et al. (2007). Abraxas
and RAP80 form a BRCA1 protein
complex required for the DNA dam-
age response. Science 316, 1194–1198.
doi: 10.1073/pnas.0710061104
Wang, H., Wang, L., Erdjument-
Bromage, H., Vidal, M., Tempst, P.,
Jones, R. S., et al. (2004). Role of
histone H2A ubiquitination in poly-
comb silencing. Nature 431, 873–878.
doi: 10.1126/science.1139476
Weitzman, M. D., Lilley, C. E.,
and Chaurushiya, M. S. (2010).
Genomes in conﬂict: maintaining
genome integrity during virus infec-
tion. Annu. Rev. Microbiol. 64, 61–81.
doi: 10.1038/nature02985
Weitzman, M. D., Lilley, C. E., and
Chaurushiya, M. S. (2011). Chang-
ing the ubiquitin landscape during
viral manipulation of the DNA dam-
age response. FEBS Lett. 585, 2897–
2906. doi: 10.1146/annurev.micro.
112408.134016
Wu, J., Liu, C., Chen, J., and Yu, X.
(2012). RAP80 protein is important
for genomic stability and is required
for stabilizing BRCA1-A complex
at DNA damage sites in vivo. J.
Biol. Chem. 287, 22919–22926. doi:
10.1016/j.febslet.2011.04.049
Wyman, C., and Kanaar, R. (2006).
DNAdouble-strand break repair: all’s
well that ends well. Annu. Rev.
Genet. 40, 363–383. doi: 10.1074/jbc.
M112.351007
Xie, A., Hartlerode, A., Stucki, M.,
Odate, S., Puget, N., Kwok, A., et al.
(2007). Distinct roles of chromatin-
associatedproteinsMDC1and53BP1
in mammalian double-strand break
repair. Mol. Cell 28, 1045–1057. doi:
10.1146/annurev.genet.40.110405.
090451
Xu, Y., Sun, Y., Jiang, X., Ayrapetov,
M. K., Moskwa, P., Yang, S.,
et al. (2010). The p400 ATPase
regulates nucleosome stability and
chromatin ubiquitination during
DNA repair. J. Cell Biol. 191, 31–
43. doi: 10.1016/j.molcel.2007.12.
005
Yin, Y., Seifert, A., Chua, J. S., Maure,
J. F., Golebiowski, F., and Hay, R.
T. (2012). SUMO-targeted ubiqui-
tin E3 ligase RNF4 is required for
the response of human cells to DNA
damage. Genes Dev. 26, 1196–1208.
doi: 10.1083/jcb.201001160
Yoo, N. J., Park, S. W., and Lee,
S. H. (2011). Frameshift muta-
tions of ubiquitination-related genes
HERC2, HERC3, TRIP12, UBE2Q1
and UBE4B in gastric and colorectal
carcinomas with microsatellite insta-
bility. Pathology 43, 753–755. doi:
10.1101/gad.189274.112
Yun, M. H., and Hiom, K. (2009).
Understanding the functions of
BRCA1 in the DNA-damage
response. Biochem. Soc. Trans.
37, 597–604. doi: 10.1097/PAT.
0b013e32834c7e78
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 31 March 2013; accepted: 14
June 2013; published online: 09 July 2013.
Citation: Bartocci C and Denchi EL
(2013) Put a RING on it: regulation and
inhibition of RNF8 and RNF168 RING
ﬁnger E3 ligases at DNA damage sites.
Front. Genet. 4:128. doi: 10.3389/fgene.
2013.00128
This article was submitted to Frontiers in
Cancer Genetics, a specialty of Frontiers
in Genetics.
Copyright © 2013 Bartocci and Denchi.
This is an open-access article distributed
under the terms of the Creative Commons
Attribution License, which permits use,
distribution and reproduction in other
forums, provided the original authors and
source are credited and subject to any
copyright notices concerning any third-
party graphics etc.
Frontiers in Genetics | Cancer Genetics July 2013 | Volume 4 | Article 128 | 12
